US$ 23.78
ghk-cu cancer The potential of GHK as an anti-aging peptide ghk-cu and cancer GHK-Cu Peptide
Description
Since there is no FDA-approved GHK-Cu drug, responsible physicians inform patients about the uncertain evidence

Trial registration The Institute of Regenerative and Cellular Medicine IRB approval number: IRCM-2021304

In vitro , in a colon epithelial cell line (Caco-2), TNF-induced increases in TJ permeability were associated with increased nuclear factor kappa beta (NF-B) activation and nuclear translocation of NF-B p65 [13]

ZIRABEV (biosimilar